bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-71-3416

Order Name:
Caris - MI Tumor seek - NGS only, tissue (FFPE) **

 
Useful For:
MI Tumor Seek is a Next-Generation Sequencing (NGS)-based tumor profiling assay that covers DNA mutations, copy number alterations, insertions/deletions, and RNA fusions for select lineages. Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) are also included with every order to inform immunotherapy opportunities.
 
Methodology:
Next-generation sequencing (NGS)
 
Test List In Profile:
All Biomarker Analysis includes:
DNA Mutation, Copy Number Alterations, Insertions/Deletions    
Genomic Signatures: MSI, TMB
RNA Fusion Analysis
 
 
AliasesName:
Comprehensive Genomic Profiling, Tissue
 
 
 
Test Code:
090-71-3416

Order Name:
Caris - MI Tumor seek - NGS only, tissue (FFPE) **

 
Collection Specimen Or Container:
Tissue/ Formalin-fixed paraffin-embedded (FFPE) block
 
Specimen Testing Type:
NGS: FFPE block or 10 unstained slides with a minimum of 20% malignant origin for DNA and 10% malignant origin for RNA. Needle biopsy is also acceptable (4-6 cores).

 
 
Sub Mission Container:
Specimen collection kit
 
Rejection Criteria:
Specimen was insufficient for testing (Low cellularity, Low tumor purity, DNA highly fragmentation, Low of RNA quality)
 
 
 
Test Code:
090-71-3416

Order Name:
Caris - MI Tumor seek - NGS only, tissue (FFPE) **

 
Method detail:
Next-generation sequencing (NGS)
 
Schedule:
N/A **Sent out to Caris, USA
 
Turnaround Time:
Received specimen to report 20-30 days (Slide received to report)
 
Performing Location:
Caris Life Sciences, USA
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code:
090-71-3416

Order Name:
Caris - MI Tumor seek - NGS only, tissue (FFPE) **

 
 
Reference Value:
An interpretive report will be provided.
 
Clinical Reference:
www.carislifesciences.com (Retrieved: 25 Jun 2020)